How long can you live after surgery for early lung cancer

The patient's treatment plan is also more important. Whether the treatment plan is suitable for the patient's physique, whether the operation is successful, whether the radiotherapy and chemotherapy are effective, whether the cancer cells are completely eliminated and other factors have a certain relationship with the patient's life expectancy. Early lung cancer can basically achieve satisfactory treatment results through scientific and effective treatment plans, timely removal of lesioned tissue, and chemotherapy or radiotherapy according to the patient's own conditions. Lung cancer is a very serious malignant tumor. If early lung cancer patients can be discovered, diagnosed and treated early, most patients can be completely cured through radical surgical resection and will not affect their life expectancy.

Why do women get lung cancer?

It is not that women are more likely to get lung cancer. There are great differences between men and women in different pathological subtypes of lung cancer. Generally speaking, the incidence of squamous cell lung cancer or small cell lung cancer in men is much higher than that in women, which is mainly related to the amount of smoking in men. According to global statistics in 2018, the incidence and mortality of lung cancer in men ranked first among malignant tumors. As the disease progresses, patients may experience symptoms such as chest tightness, chest pain, and dyspnea. With the development of the economy and the increasing incidence of lung cancer year by year, it is recommended to have a regular physical examination every year to detect the disease and treat it in time.

How is lung cancer treated with targeted drugs?

If a specific therapeutic target cannot be found, anti-vascular targeted drugs can be used for treatment, or chemotherapy, immunotherapy and other means can be used for treatment, which can also achieve a certain therapeutic effect. Targeted drugs have a good therapeutic effect on lung cancer, but they are mainly targeted at non-small cell lung cancer. Generally speaking, among all lung cancer patients, only about 25% are suitable for targeted drugs, and not all are effective;